Miszczuk-Jamska B, Chevalier F, Maire I, Dembińska-Kieć A
Department of Clinical Biochemistry, Univ. Medical School, Cracow, Poland.
J Physiol Pharmacol. 1993 Dec;44(4):345-50.
Acid lipase activity (ALA) and neutral lipase activity (NLA) in lymphocytes of patients with primary hyperlipidemia (hypercholesterolemia or/and hypertriglyceridemia) were compared with that of an age-matched control group (blood donors). The specificity of lipase was confirmed by the use of cardiolipin the well known activator of acidic lipase. beta-D-glucuronidase activity was used as a marker of the lysosomal release reaction. ALA (by 33%) and beta-D-glucuronidase (by 55%) activity, but not NLA in lymphocytes of the group of hyperlipidemic patients, was significantly lower when compared to the control group. A negative correlation between the serum cholesterol level and ALA, NLA and beta-D-glucuronidase release from lymphocytes of hyperlipidemic subjects was observed. The serum HDL cholesterol level was positively correlated with ALA within this group. These results suggest that the high cholesterol level in serum can unspecifically supress ALA and (to the smaller degree) NLA activity in lymphocytes of hyperlipidemic subjects. The decrease of lipase activity may promote deposition of lipids in cells and the development of atherosclerosis. The parallel decrease of beta-D-glucuronidase activity in lymphocytes of hypercholesterolemic patients suggests the impairment of immune system in hypercholesterolemia.
将原发性高脂血症(高胆固醇血症或/和高甘油三酯血症)患者淋巴细胞中的酸性脂肪酶活性(ALA)和中性脂肪酶活性(NLA)与年龄匹配的对照组(献血者)进行比较。通过使用酸性脂肪酶的著名激活剂心磷脂来确认脂肪酶的特异性。β-D-葡萄糖醛酸酶活性用作溶酶体释放反应的标志物。与对照组相比,高脂血症患者组淋巴细胞中的ALA活性(降低33%)和β-D-葡萄糖醛酸酶活性(降低55%)显著降低,但NLA活性未降低。观察到高脂血症患者血清胆固醇水平与淋巴细胞中ALA、NLA和β-D-葡萄糖醛酸酶释放之间呈负相关。该组血清高密度脂蛋白胆固醇水平与ALA呈正相关。这些结果表明,血清中高胆固醇水平可非特异性抑制高脂血症患者淋巴细胞中的ALA活性以及(程度较小的)NLA活性。脂肪酶活性降低可能促进脂质在细胞中的沉积和动脉粥样硬化的发展。高胆固醇血症患者淋巴细胞中β-D-葡萄糖醛酸酶活性的平行降低表明高胆固醇血症中免疫系统受损。